Aspect Biosystems

Tamer Mohamed, President and CEO

April 20 | 2:30pm | Gaudi 2 Ballroom

Vancouver, Canada


In-Person Presentation

Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics as medicines of the future. Aspect is applying its microfluidic 3D bioprinting technology internally to develop these advanced cell therapies and partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.

By using this website you agree to accept our Privacy Policy and Terms & Conditions